Department of Health Policy and Management, School of Public Health, Peking University, Beijing, China.
China Center for Health Development Studies, Peking University, Beijing, China.
Trials. 2024 Oct 28;25(1):721. doi: 10.1186/s13063-024-08563-2.
In supporting primary healthcare in delivering high-quality care for individuals with type 2 diabetes mellitus (T2DM), previous research emphasized strategies to facilitate communication and collaboration between primary healthcare providers and hospitals. This study aims to evaluate the effectiveness of case discussion conferences between specialists from hospitals and primary healthcare providers in China on the optimization of diabetes management and the improvement of patient health outcomes.
This study will be a parallel cluster randomized controlled trial in which primary healthcare institutions in Shouguang city and Shangsi County will be randomly allocated to the intervention and control groups. The intervention will involve regular case discussion conferences where attendants will meet to discuss complex cases with patients diagnosed with type 2 diabetes mellitus, exchange experiences, and seek and provide expert advice. Family doctor teams from primary healthcare institutions and specialists from secondary or tertiary hospitals will engage in these conferences. Data will be collected at baseline and at the 6- and 12-month follow-ups. The primary clinical outcome measures will focus on the changes in the HbA1c and FBG levels of patients under management. The secondary outcomes will include other physiological indicators, such as blood pressure, BMI, and cholesterol. The evaluation will extend to changes in the capabilities and behaviors of primary healthcare providers. Furthermore, the feasibility and adherence of this intervention will be thoroughly assessed.
This study is designed to generate robust evidence on the effectiveness of case discussion conferences, an interprofessional collaboration strategy, in enhancing diabetes care delivery in primary healthcare, with the ultimate goal of improving patient health outcomes.
Chinese Clinical Trial Registry ChiCTR2300078829. Registered on December 19, 2023. https://www.chictr.org.cn/showproj.html?proj=210293.
在支持基层医疗保健为 2 型糖尿病患者提供高质量护理方面，先前的研究强调了促进基层医疗保健提供者和医院之间沟通和协作的策略。本研究旨在评估中国医院专科医生和基层医疗保健提供者之间的病例讨论会议在优化糖尿病管理和改善患者健康结果方面的效果。
这将是一项平行集群随机对照试验，寿光市和上思县的基层医疗机构将被随机分配到干预组和对照组。干预措施将包括定期的病例讨论会议，与会者将讨论患有 2 型糖尿病的复杂病例，交流经验，并寻求和提供专家建议。基层医疗机构的家庭医生团队和二级或三级医院的专家将参加这些会议。数据将在基线和 6 个月及 12 个月随访时收集。主要临床结局指标将集中在管理患者的 HbA1c 和 FBG 水平变化上。次要结局将包括其他生理指标，如血压、BMI 和胆固醇。评估还将扩展到基层医疗保健提供者能力和行为的变化。此外，还将彻底评估这种干预的可行性和依从性。
本研究旨在为病例讨论会议这一跨专业合作策略在加强基层医疗保健中的糖尿病护理提供有力的证据，最终目标是改善患者的健康结果。
中国临床试验注册中心 ChiCTR2300078829。注册于 2023 年 12 月 19 日。www.chictr.org.cn/showproj.html?proj=210293。
